Syndrome of rapid onset end stage renal disease in incident Mayo Clinic chronic hemodialysis patient

Indian Journal of Nephrology

Volumn 24, Issue 2, 2014, Pages 75-81

  Onuigbo, M A C ^a,b,c   Onuigbo, N ^d   Musso, C ^e  

^a MAYO CLINIC   (United States)

^b Mayo Clinic Health System   (United States)

^c Healthcare Executive   (United States)

^d NTEC Solutions LLC   (United States)

^e HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Acute kidney injury; chronic kidney disease; end stage renal disease; renal replacement therapy

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CREATININE; VASODILATOR AGENT;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DISEASE COURSE; END STAGE RENAL DISEASE; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE PERIOD; PYELONEPHRITIS; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; SEPSIS; SYNDROME OF RAPID ONSET END STAGE RENAL DISEASE; TIME TO TREATMENT; UNITED STATES; VERY ELDERLY;

EID: 84896775332     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.127886     Document Type: Article

References (38)

1. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK. Acute kidney injury: A springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010;298:F1078-94.
2. Onuigbo MA, Onuigbo NT. The syndrome of rapid onset end-stage renal disease-A new mayo clinic dialysis services experience, January 2010-February 2011. In: Di Iorio B, Heidland A, Onuigbo M, Ronco C, editors. Hemodialysis: How, When and Why. Hauppauge NY: NOVA Science Publishers; 2012. p. 443-85.
3. The GISEN Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) Lancet 1997;349:1857-63.
4. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007;18:2758-65.
5. Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 2008;109:c109-18.
6. Yoshida T, Takei T, Shirota S, Tsukada M, Sugiura H, Itabashi M, et al. Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population. Intern Med 2008;47:1859-64.
7. Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, et al. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 2009;24:1930-7.
8. Ponte B, Felipe C, Muriel A, Tenorio MT, Liaño F. Long-Term functional evolution after an acute kidney injury: A 10-year study. Nephrol Dial Transplant 2008;23:3859-66.
9. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009;302:1179-85.
10. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009;20:223-8.
11. Onuigbo M, Onuigbo N, editors. In: Chronic Kidney Disease and RAAS Blockade: A New View of Renoprotection. London, England: Lambert Academic Publishing GmbH 11 and Co. KG; 2011.
12. Onuigbo MA. Syndrome of rapid-onset end-stage renal disease: A new unrecognized pattern of CKD progression to ESRD. Ren Fail 2010;32:954-8.
13. Musso CG, Oreopoulos DG. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol 2011;119 Suppl 1:p1-5.
14. Musso CG, Reynaldi J, Martinez B, Pierángelo A, Vilas M, Algranati L. Renal reserve in the oldest old. Int Urol Nephrol 2011;43:253-6.
15. Onuigbo MA. Evidence of the syndrome of rapid onset end-stage renal disease (SORO-ESRD) in the acute kidney injury (AKI) literature-Preventable causes of AKI and SORO-ESRD-A call for re-engineering of nephrology practice paradigms. Ren Fail 2013;35:796-800.
16. Firth JD. Acute irreversible renal failure. QJM 1996;89:397-9.
17. Lee P, Johansen K, Hsu CY. End-stage renal disease preceded by rapid declines in kidney function: A case series. BMC Nephrol 2011;12:5.
18. O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of long-Term dialysis. Am J Kidney Dis 2012;59:513-22.
19. Siddiqui NF, Coca SG, Devereaux PJ, Jain AK, Li L, Luo J, et al. Secular trends in acute dialysis after elective major surgery-1995 to 2009. CMAJ 2012;184:1237-45.
20. Onuigbo MA. Increasing trends in acute dialysis after elective surgery, 1995-2009: How often does AKI directly lead to irreversible ESRD all in one fell swoop? Can Med Assoc J Published Online, July 13, 2012.
21. Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM 1996;89:415-21.
22. Onuigbo MA, Onuigbo NT. Late onset renal failure from angiotensin blockade: A prospective thirty-month mayo health system clinic experience. Med Sci Monit 2005;11:CR462-9.
23. Onuigbo MA, Onuigbo NT. Late-onset renal failure from angiotensin blockade in 100 CKD patients. Int Urol Nephrol 2008;40:233-9.
24. Onuigbo MA. Reno-prevention vs. reno-protection: A critical re-Appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET-A call for more circumspection. QJM 2009;102:155-67.
25. Onuigbo MA. Renoprevention: A new concept for reengineering nephrology care-An economic impact and patient outcome analysis of two hypothetical patient management paradigms in the CCU. Ren Fail 2013;35:23-8.
26. Onuigbo MA. The nephrotoxic 'triple whammy' of combining diuretics, ACE inhibitors, and NSAIDs [corrected]. BMJ 2013;346:f678.
27. Onuigbo MA. Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients? Nephron Clin Pract 2011;118:c407-19.
28. Musso CG. Geriatric nephrology and the 'nephrogeriatric giants'. Int Urol Nephrol 2002;34:255-6.
29. Musso CG, Liakopoulos V, Ioannidis I, Eleftheriadis T, Stefanidis I. Acute renal failure in the elderly: Particular characteristics. Int Urol Nephrol. 2006;38:787-93.
30. Musso CG, Macías-Núñez JF. Renal handling of water and electrolytes in the old and old-old healthy aged. In: Núñez M, Cameron S, Oreopoulos D, editors. The ageing kidney in health and disease. New York: Springer; 2008:141-54.
31. Lacy C, Armstrong L, Goldman M, Lance L, editors. Drug Information Handbook. Ohio: Lexi-Comp; 2004. p. 526-30.
32. Jong P. Angiotensin I converting enzyme inhibitors and angiotensin II receptor antagonist. In: De Broe M, Porter G, Bennett W, Deray G, editors. Clinical Nephrotoxins. New York: Springer; 2008. p. 481-94.
33. Ballerman BJ, Onuigbo MA. Angiotensins. In: Fray JC, editor. Handbook of Physiology: The Endocrine System: Endocrine Regulation of Water and Electrolyte Balance. Section 7, Ch. 4, Vol. 3. New York, Oxford: Oxford University Press; 2000. p. 104-54.
34. Onuigbo MA, Onuigbo NT. Angiotensin converting enzyme inhibitors. In: DeBrue AN, editor. Angiotensin Converting Enzyme Inhibitors. New York: Nova Biomedical Books Published by Nova Science Publishers; 2009. p. 1-41.
35. Vendemia F. The diagnosis of renal diseases in elderly patients. What role is there for biopsy? In: Núñez M, Cameron S, Oreopoulos D, editors. Renal Ageing: Health and Disease. New York, US: Springer; 2008. p. 307-27.
36. Onuigbo MA. Syndrome of rapid-onset end-stage renal disease in two consecutive renal transplant recipients. Indian J Nephrol 2013;23:222-5.
37. Onuigbo MA. The CKD enigma with misleading statistics and myths about CKD, and conflicting ESRD and death rates in the literature: Results of a 2008 US population-based cross-sectional CKD outcomes analysis. Ren Fail 2013;35:338-43.
38. Bansal N, Hsu CY. Long-Term outcomes of patients with chronic kidney disease. Nat Clin Pract Nephrol 2008;4:532-3.